The modern healthcare data stack unifies patient data for real-time clinical and operational insights to improve decision-making in health systems.

AIwithCare features a software platform that uses generative AI to screen patients for clinical trial eligibility.

NetraMark Holdings Inc. (the “Company” or “NetraMark”) (CSE: AIAI) (OTCQB: AINMF) (Frankfurt: PF0), a premier artificial intelligence (AI) company transforming clinical trials with AI-powered ...

LEWES, Del., Dec. 15, 2025 (GLOBE NEWSWIRE) -- John Snow Labs, a healthcare AI company, today announced that its Medical LLMs have been named a winner in FoundryCo.'s InfoWorld Technology of the Year ...

The VA is accelerating a systemwide rollout of its new electronic health records platform, with full deployment at all ...

Mass General Brigham is announcing the spinout of AIwithCare, a company founded by researchers from the health system who developed an artificial intelligence (AI) screening tool that significantly ...

Discover why IQVIA Holdings leads in life sciences data & tech with AI-driven services, strong growth, and up to 30% stock ...

The surge of investment grade AI infrastructure debt has mesmerized fixed income investors, but the non-investment grade ...

Navigating the SaMD regulatory pathways is one of the most complex yet important aspects of product development for medical technology startups. Startups in this field are required to meet local ...

WASHINGTON, DC / ACCESS Newswire / December 9, 2025 / Black Book Research today announced the release of new survey results, 2026 U.S. Healthcare Technology Regulatory Outlook: Federal, State & Local ...